Skip to Main Content

Paper Details

Suppression of multiple anti-apoptotic BCL2 family proteins recapitulates the effects of JAK2 inhibitors in JAK2V617F driven myeloproliferative neoplasms.
Cancer Sci
1
2022
BCL-XL, BCL2, BH3, Bcl-xl, Bcl2l1, Bcl2l1f, JAK2, JAK2V617F, JAK2V617F cell models, Jak2V617F, Jak2V617W/VF, MPN, Mx1-Cre, Vav, anemia, anti-apoptotic BCL2 family proteins, erythroid progenitors, mice, mouse, murine, myeloid-erythroid precursors, myeloproliferative neoplasms, neoplastic, neoplastic cells, obatoclax, ruxolitinib, splenomegaly, stem cell, terminal differentiation stage, terminal differentiation stage neoplastic cells, terminally differentiated erythroid, terminally differentiated erythroid progenitors, thrombocytopenia
Author NameAffiliation
Robert S WelnerUniversity of Alabama at Birmingham
Robert S WelnerUniversity of Alabama at Birmingham
  • 1 - 2

Datasets

Release 1.2